Develops small-molecule drugs for treatment of immunological, viral, and cardiovascular diseases and disorders, using structure-based drug design. Includes programs, trials and investors' profile, with headquarters in Birmingham, Alabama. (Nasdaq: BCRX)
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.
2024-08-23
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Research and Development - BioCryst Pharmaceuticals, Inc.. Develops small-molecule drugs for treatment of immunological, viral, and cardiovascular diseases and disorders, using structure-based drug design.